¾Ã²Ý¸£Àû and events

¾Ã²Ý¸£Àû stories

¾Ã²Ý¸£Àû related to gene therapy at the University of Sheffield and related events.
A person smiling at the camera in a grey suit.

Professor Chris McDermott appointed as new Director of NIHR Sheffield Biomedical Research Centre

The University of Sheffield is proud to announce that Professor Chris McDermott, Professor of Translational Neurology at the University of Sheffield, has been appointed as the new Director of the NIHR Sheffield Biomedical Research Centre.
The University of Sheffield AMRC is a hugely successful advanced manufacturing research centre that has set a new standard for academic and industry R&D.

University of Sheffield welcomes ambitious plan for growth in South Yorkshire

The University of Sheffield has welcomed the publication of the South Yorkshire Growth Plan which sets out the region’s economic priorities for the next 10 years.  
Aerial view of Diamond and city skyline

University of Sheffield a national leader in working with businesses and communities

The University of Sheffield has once again been recognised as one of the best universities in England for collaborating and engaging with businesses, communities and the public, according to the Knowledge Exchange Framework (KEF) 2025.
exterior of GTIMC facility

We are hiring technical staff in Sheffield, UK!

Come and join us to develop the gene therapies of tomorrow
Bricks being laid at SITraN

New chapter in Sheffield’s world-renowned neuroscience research

New development at the University of Sheffield will double the research capacity of the world-leading research facility, accelerating the progress of breakthrough treatments for neurological diseases such as Parkinson's, Alzheimer's and MND.

Image of motor neurones

Sheffield scientist awarded prestigious prize for ground breaking MND research

Dr Johnathan Cooper-Knock from the University of Sheffield is one of eight outstanding scientists nationwide to receive the 2025 Lister Award in recognition of his pioneering MND research.
Neuron cells system - 3d rendered image of Neuron cell network on black background

University spinout company awarded £2.3 million to develop breakthrough therapies that address underlying causes of MND

Crucible Therapeutics and University of Sheffield secure a £2.3 million Innovate UK Biomedical Catalyst award to develop breakthrough siRNA therapies that address underlying causes of Motor Neuron Disease (MND).
Visual representation Runway Park

Runway Park: A vision for innovation-led growth takes flight

A transformative University of Sheffield development designed to attract investment, create high-quality jobs and accelerate economic growth unveils its new look as Runway Park is officially launched to industry.
DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).